Wegovy undergoes centralized FDA oversight with pre-filled pens containing fixed doses at 0.25 mg, 0.5 mg, 1 mg, and 2.4 mg increments
Pre-meal substitute that doubles as a small breakfast
She emphasizes the importance of patient education and thorough screening to identify individuals at higher risk for these side effects
The Phase 3 TRIUMPH-4 trial confirmed and exceeded those expectations
CrossRef Hypertension in middle childhood Mirjam Monik, Zala Hrovat, Sonja Golob Jani, Martina Filipi, Mladen Crnobrnja, Nataa Marun Varda BMC Pediatrics .2026;[Epub] CrossRef Blood-based non-invasive tests show comparable accuracy in MetALD and MASLD for MRE-defined advanced fibrosis Akash Roy, Surabhi Jajodia, Shardhya Chakraborty, Shruti Keyal, Awanish Tewari, Nikhil Sonthalia, Sourish Roy, Rajat Khandelwal, Anand Kulkarni, Uday Chand Ghoshal, Rajender Reddy, Mahesh Kumar Goenka BMC Gastroenterology .2026;[Epub] CrossRef Current Drug Development Pipeline for MASLD and MASH: Focusing on Cardiovascular Comorbidities Veronika A